 | • レポートコード：QYR9NV13951 • 出版社/出版日：QYResearch / 2019年11月16日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・ヘルスケア |
| Single User | ￥525,000 (USD3,500) | ▷ お問い合わせ |
| Enterprise License | ￥1,050,000 (USD7,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートは、尿管がん薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、デュルバルマブ、メシル酸エリブリン、ペンブロリズマブ、その他に、用途別には、入院患者、外来患者にセグメント区分し、尿管がん薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・尿管がん薬の世界市場概要 ・尿管がん薬の製造コスト構成分析 ・尿管がん薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・尿管がん薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・尿管がん薬のセグメント分析（種類別） （デュルバルマブ、メシル酸エリブリン、ペンブロリズマブ、その他） ・尿管がん薬のセグメント分析（用途別） （入院患者、外来患者） ・尿管がん薬の主要メーカー別分析（生産拠点、製品概要、生産・売上実績） （Altor BioScience Corp、Eisai Co Ltd、Exelixis Inc、GlaxoSmithKline Plc、MedImmune LLC、Merck & Co Inc、） ・尿管がん薬の市場規模予測（2019年～2025年） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・マーケティングチャネル・流通業者・顧客 ・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子） ... |
The global Ureter Cancer Drugs market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Ureter Cancer Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Ureter Cancer Drugs market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Ureter Cancer Drugs in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Ureter Cancer Drugs manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Altor BioScience Corp
Eisai Co Ltd
Exelixis Inc
GlaxoSmithKline Plc
MedImmune LLC
Merck & Co Inc
…
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Durvalumab
Eribulin Mesylate
Pembrolizumab
Others
Segment by Application
In-Patient
Out-Patient
Table of Contents
Executive Summary
1 Industry Overview of Ureter Cancer Drugs
1.1 Definition of Ureter Cancer Drugs
1.2 Ureter Cancer Drugs Segment by Type
1.2.1 Global Ureter Cancer Drugs Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Durvalumab
1.2.3 Eribulin Mesylate
1.2.4 Pembrolizumab
1.2.5 Others
1.3 Ureter Cancer Drugs Segment by Applications
1.3.1 Global Ureter Cancer Drugs Consumption Comparison by Applications (2014-2025)
1.3.2 In-Patient
1.3.3 Out-Patient
1.4 Global Ureter Cancer Drugs Overall Market
1.4.1 Global Ureter Cancer Drugs Revenue (2014-2025)
1.4.2 Global Ureter Cancer Drugs Production (2014-2025)
1.4.3 North America Ureter Cancer Drugs Status and Prospect (2014-2025)
1.4.4 Europe Ureter Cancer Drugs Status and Prospect (2014-2025)
1.4.5 China Ureter Cancer Drugs Status and Prospect (2014-2025)
1.4.6 Japan Ureter Cancer Drugs Status and Prospect (2014-2025)
1.4.7 Southeast Asia Ureter Cancer Drugs Status and Prospect (2014-2025)
1.4.8 India Ureter Cancer Drugs Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Ureter Cancer Drugs
2.3 Manufacturing Process Analysis of Ureter Cancer Drugs
2.4 Industry Chain Structure of Ureter Cancer Drugs
3 Development and Manufacturing Plants Analysis of Ureter Cancer Drugs
3.1 Capacity and Commercial Production Date
3.2 Global Ureter Cancer Drugs Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Ureter Cancer Drugs
3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
4.1 Ureter Cancer Drugs Production and Capacity Analysis
4.2 Ureter Cancer Drugs Revenue Analysis
4.3 Ureter Cancer Drugs Price Analysis
4.4 Market Concentration Degree
5 Ureter Cancer Drugs Regional Market Analysis
5.1 Ureter Cancer Drugs Production by Regions
5.1.1 Global Ureter Cancer Drugs Production by Regions
5.1.2 Global Ureter Cancer Drugs Revenue by Regions
5.2 Ureter Cancer Drugs Consumption by Regions
5.3 North America Ureter Cancer Drugs Market Analysis
5.3.1 North America Ureter Cancer Drugs Production
5.3.2 North America Ureter Cancer Drugs Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Ureter Cancer Drugs Import and Export
5.4 Europe Ureter Cancer Drugs Market Analysis
5.4.1 Europe Ureter Cancer Drugs Production
5.4.2 Europe Ureter Cancer Drugs Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Ureter Cancer Drugs Import and Export
5.5 China Ureter Cancer Drugs Market Analysis
5.5.1 China Ureter Cancer Drugs Production
5.5.2 China Ureter Cancer Drugs Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Ureter Cancer Drugs Import and Export
5.6 Japan Ureter Cancer Drugs Market Analysis
5.6.1 Japan Ureter Cancer Drugs Production
5.6.2 Japan Ureter Cancer Drugs Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Ureter Cancer Drugs Import and Export
5.7 Southeast Asia Ureter Cancer Drugs Market Analysis
5.7.1 Southeast Asia Ureter Cancer Drugs Production
5.7.2 Southeast Asia Ureter Cancer Drugs Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Ureter Cancer Drugs Import and Export
5.8 India Ureter Cancer Drugs Market Analysis
5.8.1 India Ureter Cancer Drugs Production
5.8.2 India Ureter Cancer Drugs Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Ureter Cancer Drugs Import and Export
6 Ureter Cancer Drugs Segment Market Analysis (by Type)
6.1 Global Ureter Cancer Drugs Production by Type
6.2 Global Ureter Cancer Drugs Revenue by Type
6.3 Ureter Cancer Drugs Price by Type
7 Ureter Cancer Drugs Segment Market Analysis (by Application)
7.1 Global Ureter Cancer Drugs Consumption by Application
7.2 Global Ureter Cancer Drugs Consumption Market Share by Application (2014-2019)
8 Ureter Cancer Drugs Major Manufacturers Analysis
8.1 Altor BioScience Corp
8.1.1 Altor BioScience Corp Ureter Cancer Drugs Production Sites and Area Served
8.1.2 Altor BioScience Corp Product Introduction, Application and Specification
8.1.3 Altor BioScience Corp Ureter Cancer Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Eisai Co Ltd
8.2.1 Eisai Co Ltd Ureter Cancer Drugs Production Sites and Area Served
8.2.2 Eisai Co Ltd Product Introduction, Application and Specification
8.2.3 Eisai Co Ltd Ureter Cancer Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Exelixis Inc
8.3.1 Exelixis Inc Ureter Cancer Drugs Production Sites and Area Served
8.3.2 Exelixis Inc Product Introduction, Application and Specification
8.3.3 Exelixis Inc Ureter Cancer Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 GlaxoSmithKline Plc
8.4.1 GlaxoSmithKline Plc Ureter Cancer Drugs Production Sites and Area Served
8.4.2 GlaxoSmithKline Plc Product Introduction, Application and Specification
8.4.3 GlaxoSmithKline Plc Ureter Cancer Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 MedImmune LLC
8.5.1 MedImmune LLC Ureter Cancer Drugs Production Sites and Area Served
8.5.2 MedImmune LLC Product Introduction, Application and Specification
8.5.3 MedImmune LLC Ureter Cancer Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Merck & Co Inc
8.6.1 Merck & Co Inc Ureter Cancer Drugs Production Sites and Area Served
8.6.2 Merck & Co Inc Product Introduction, Application and Specification
8.6.3 Merck & Co Inc Ureter Cancer Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
9 Development Trend of Analysis of Ureter Cancer Drugs Market
9.1 Global Ureter Cancer Drugs Market Trend Analysis
9.1.1 Global Ureter Cancer Drugs Market Size (Volume and Value) Forecast 2019-2025
9.2 Ureter Cancer Drugs Regional Market Trend
9.2.1 North America Ureter Cancer Drugs Forecast 2019-2025
9.2.2 Europe Ureter Cancer Drugs Forecast 2019-2025
9.2.3 China Ureter Cancer Drugs Forecast 2019-2025
9.2.4 Japan Ureter Cancer Drugs Forecast 2019-2025
9.2.5 Southeast Asia Ureter Cancer Drugs Forecast 2019-2025
9.2.6 India Ureter Cancer Drugs Forecast 2019-2025
9.3 Ureter Cancer Drugs Market Trend (Product Type)
9.4 Ureter Cancer Drugs Market Trend (Application)
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Ureter Cancer Drugs Customers
11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors
12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer
Figure Picture of Ureter Cancer Drugs
Table Global Ureter Cancer Drugs Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global Ureter Cancer Drugs Production Market Share by Types in 2018
Figure Durvalumab Product Picture
Figure Eribulin Mesylate Product Picture
Figure Pembrolizumab Product Picture
Figure Others Product Picture
Table Global Ureter Cancer Drugs Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global Ureter Cancer Drugs Consumption Market Share by Applications in 2018
Figure In-Patient
Figure Out-Patient
Figure Global Ureter Cancer Drugs Revenue (Million USD) (2014-2025)
Figure Global Ureter Cancer Drugs Production (K Pcs) (2014-2025)
Figure North America Ureter Cancer Drugs Market Size (Million USD) (2014-2025)
Figure Europe Ureter Cancer Drugs Market Size (Million USD) (2014-2025)
Figure China Ureter Cancer Drugs Market Size (Million USD) (2014-2025)
Figure Japan Ureter Cancer Drugs Market Size (Million USD) (2014-2025)
Figure Southeast Asia Ureter Cancer Drugs Market Size (Million USD) (2014-2025)
Figure India Ureter Cancer Drugs Market Size (Million USD) (2014-2025)
Table Ureter Cancer Drugs Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Ureter Cancer Drugs in 2018
Figure Manufacturing Process Analysis of Ureter Cancer Drugs
Figure Industry Chain Structure of Ureter Cancer Drugs
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Ureter Cancer Drugs Manufacturing Plants Distribution
Table Ureter Cancer Drugs Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Ureter Cancer Drugs Capacity (K Pcs) of Major Manufacturers (2014-2019)
Table Ureter Cancer Drugs Production (K Pcs) of Major Manufacturers (2014-2019)
Table Ureter Cancer Drugs Production Market Share of Major Manufacturers (2014-2019)
Figure Ureter Cancer Drugs Production Share by Manufacturers in 2018
Table Ureter Cancer Drugs Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Ureter Cancer Drugs Revenue Market Share of Major Manufacturers (2014-2019)
Figure Ureter Cancer Drugs Revenue Share by Manufacturers in 2018
Table Ureter Cancer Drugs Average Price (USD/Pcs) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Ureter Cancer Drugs Production by Regions 2014-2019 (K Pcs)
Table Global Ureter Cancer Drugs Production Market Share by Regions 2014-2019
Figure Global Ureter Cancer Drugs Production Market Share by Regions in 2018
Table Global Ureter Cancer Drugs Revenue by Regions 2014-2019 (Million USD)
Table Global Ureter Cancer Drugs Revenue Market Share by Regions 2014-2019
Figure Global Ureter Cancer Drugs Revenue Market Share by Regions in 2018
Table Global Ureter Cancer Drugs Consumption by Regions 2014-2019 (K Pcs)
Table Global Ureter Cancer Drugs Consumption Market Share by Regions 2014-2019
Figure North America Ureter Cancer Drugs Production Growth Rate 2014-2019 (K Pcs)
Figure North America Ureter Cancer Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table North America Ureter Cancer Drugs Production, Consumption Import and Export (K Pcs)
Figure Europe Ureter Cancer Drugs Production Growth Rate 2014-2019 (K Pcs)
Figure Europe Ureter Cancer Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Ureter Cancer Drugs Production, Consumption Import and Export (K Pcs)
Figure China Ureter Cancer Drugs Production Growth Rate 2014-2019 (K Pcs)
Figure China Ureter Cancer Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table China Ureter Cancer Drugs Production, Consumption Import and Export (K Pcs)
Figure Japan Ureter Cancer Drugs Production Growth Rate 2014-2019 (K Pcs)
Figure Japan Ureter Cancer Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Ureter Cancer Drugs Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia Ureter Cancer Drugs Production Growth Rate 2014-2019 (K Pcs)
Figure Southeast Asia Ureter Cancer Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Ureter Cancer Drugs Production, Consumption Import and Export (K Pcs)
Figure India Ureter Cancer Drugs Production Growth Rate 2014-2019 (K Pcs)
Figure India Ureter Cancer Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table India Ureter Cancer Drugs Production, Consumption Import and Export (K Pcs)
Figure Global Consumption Ureter Cancer Drugs Market Share by Application (2014-2019)
Figure Global Value (Consumption) Ureter Cancer Drugs Market Share by Application (2014-2019)
Table Altor BioScience Corp Ureter Cancer Drugs Production Sites and Area Served
Table Altor BioScience Corp Ureter Cancer Drugs Product Introduction, Application and Specification
Table Altor BioScience Corp Ureter Cancer Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Altor BioScience Corp Ureter Cancer Drugs Production Growth Rate (2014-2019)
Table Altor BioScience Corp Ureter Cancer Drugs Production Market Share (2014-2019)
Figure Altor BioScience Corp Ureter Cancer Drugs Revenue Market Share (2014-2019)
Table Altor BioScience Corp Ureter Cancer Drugs Main Business and Markets Served
Table Eisai Co Ltd Ureter Cancer Drugs Production Sites and Area Served
Table Eisai Co Ltd Ureter Cancer Drugs Product Introduction, Application and Specification
Table Eisai Co Ltd Ureter Cancer Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Eisai Co Ltd Ureter Cancer Drugs Production Growth Rate (2014-2019)
Table Eisai Co Ltd Ureter Cancer Drugs Production Market Share (2014-2019)
Figure Eisai Co Ltd Ureter Cancer Drugs Revenue Market Share (2014-2019)
Table Eisai Co Ltd Ureter Cancer Drugs Main Business and Markets Served
Table Exelixis Inc Ureter Cancer Drugs Production Sites and Area Served
Table Exelixis Inc Ureter Cancer Drugs Product Introduction, Application and Specification
Table Exelixis Inc Ureter Cancer Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Exelixis Inc Ureter Cancer Drugs Production Growth Rate (2014-2019)
Table Exelixis Inc Ureter Cancer Drugs Production Market Share (2014-2019)
Figure Exelixis Inc Ureter Cancer Drugs Revenue Market Share (2014-2019)
Table Exelixis Inc Ureter Cancer Drugs Main Business and Markets Served
Table GlaxoSmithKline Plc Ureter Cancer Drugs Production Sites and Area Served
Table GlaxoSmithKline Plc Ureter Cancer Drugs Product Introduction, Application and Specification
Table GlaxoSmithKline Plc Ureter Cancer Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table GlaxoSmithKline Plc Ureter Cancer Drugs Production Growth Rate (2014-2019)
Table GlaxoSmithKline Plc Ureter Cancer Drugs Production Market Share (2014-2019)
Figure GlaxoSmithKline Plc Ureter Cancer Drugs Revenue Market Share (2014-2019)
Table GlaxoSmithKline Plc Ureter Cancer Drugs Main Business and Markets Served
Table MedImmune LLC Ureter Cancer Drugs Production Sites and Area Served
Table MedImmune LLC Ureter Cancer Drugs Product Introduction, Application and Specification
Table MedImmune LLC Ureter Cancer Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table MedImmune LLC Ureter Cancer Drugs Production Growth Rate (2014-2019)
Table MedImmune LLC Ureter Cancer Drugs Production Market Share (2014-2019)
Figure MedImmune LLC Ureter Cancer Drugs Revenue Market Share (2014-2019)
Table MedImmune LLC Ureter Cancer Drugs Main Business and Markets Served
Table Merck & Co Inc Ureter Cancer Drugs Production Sites and Area Served
Table Merck & Co Inc Ureter Cancer Drugs Product Introduction, Application and Specification
Table Merck & Co Inc Ureter Cancer Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Merck & Co Inc Ureter Cancer Drugs Production Growth Rate (2014-2019)
Table Merck & Co Inc Ureter Cancer Drugs Production Market Share (2014-2019)
Figure Merck & Co Inc Ureter Cancer Drugs Revenue Market Share (2014-2019)
Table Merck & Co Inc Ureter Cancer Drugs Main Business and Markets Served
Figure Global Ureter Cancer Drugs Production (K Pcs) Growth Rate Forecast 2019-2025
Figure Global Ureter Cancer Drugs Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Ureter Cancer Drugs Sales Price (USD/Pcs) Forecast 2019-2025
Figure North America Ureter Cancer Drugs Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure North America Ureter Cancer Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Ureter Cancer Drugs Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Europe Ureter Cancer Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Ureter Cancer Drugs Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure China Ureter Cancer Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Ureter Cancer Drugs Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Japan Ureter Cancer Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Ureter Cancer Drugs Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Southeast Asia Ureter Cancer Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Ureter Cancer Drugs Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure India Ureter Cancer Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Pcs) of Ureter Cancer Drugs by Type (2019-2025)
Table Global Consumption (K Pcs) of Ureter Cancer Drugs by Application (2019-2025)
Table Ureter Cancer Drugs Distributors List
Table Ureter Cancer Drugs Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
尿管がん薬のグローバル市場調査 2019年 The global Ureter Cancer Drugs market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Ureter Cancer Drugs volume and value at global level, regional level and company level. From a global perspective, this…- 食道癌治療薬のグローバル市場：規模・現状・予測2019-2025 Esophageal cancer is cancer arising from the esophagus—the food pipe that runs between the throat and the stomach.Symptoms often include difficulty in swallowing and weight loss.Other symptoms may include pain when swallowing, a hoarse voice, enlarged lymph nodes ("glands") around the collarbone, a …
- 食道癌治療薬のグローバル市場：規模・現状・予測2019-2025 Esophageal cancer is cancer arising from the esophagus—the food pipe that runs between the throat and the stomach.Symptoms often include difficulty in swallowing and weight loss.Other symptoms may include pain when swallowing, a hoarse voice, enlarged lymph nodes ("glands") around the collarbone, a …
- 世界及び中国の泌尿器がん治療薬市場2018 The 'Global and Chinese Urological Cancer Therapeutics Drugs Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Urological Cancer Therapeutics Drugs industry with a focus on the Chinese market. The report provides key statistics on the…
- 非小細胞肺がん薬のグローバル市場：規模・現状・予測2019-2025 Non-small-cell lung carcinoma (NSCLC) is any type of epithelial lung cancer other than small cell lung carcinoma (SCLC). NSCLC accounts for about 85% of all lung cancers.The strong drug pipeline and drug approvals are one of the critical factors that will trigger the non-small cell lung cancer drugs…